|

TEXT4HF: A Randomized Controlled Trial of a Tailored Text Messaging Intervention to Improve Self-Care in Older Adult Patients With Heart Failure

RECRUITINGN/ASponsored by University of Illinois at Chicago
Actively Recruiting
PhaseN/A
SponsorUniversity of Illinois at Chicago
Started2024-09-26
Est. completion2025-12-30
Eligibility
Age50 Years+
Healthy vol.Accepted
Locations1 site

Summary

The goal of this study is to determine whether an individually tailored text messaging intervention can improve self-care in older adult patients with heart failure. The main question it aims to answer are: * Is a tailored text messaging intervention feasible and acceptable among older adult patients with heart failure? * Does tailored text messaging improve self-care in adult patients with heart failure? Participants will be randomly assigned to one of two groups for 12 weeks: 1) intervention (text messaging); or 2) control group. Both groups will receive usual care, which includes regular follow-up visits at the heart failure clinic (standard care), plus a "Discharge Packet for Patients Diagnosed with Heart Failure", developed by the American Heart Association. Both groups will be asked via text messages and/or telephone calls to complete questionnaires at baseline/start, 4 weeks and 12 weeks, about self-care, quality of life, health beliefs, medications, diet, etc. Participants assigned to the intervention group will also receive approximately 5 text messages/week targeting medication adherence, heart-healthy diet, and self-monitoring for 12 weeks.

Eligibility

Age: 50 Years+Healthy volunteers accepted
Inclusion Criteria:

* ≥50 years of Age
* HF Stage C, NYHA Class I-IV and on a loop diuretic
* Own a Mobile phone with Text message plan
* Ability to speak and read English
* Suboptimal HF self-care. (SCHFI Score of 3 or less in at least 2 items of any subscale: Self-care maintenance, Symptom Perception, or Self-management)

Exclusion Criteria:

* SAVR/TAVR or Ventricular Assist Device, or Cardiac Resynchronization Therapy (CRT) - implantation, and/or heart transplantation (HTx) scheduled within the next 3 months
* Coronary revascularization, and/or CRT-implantation within the last 30 days (EMR Review)
* Psychosis
* Hospice or End-of-life care
* Advanced Renal disease (i.e., estimated Glomerular Filtration Rate \<25 or Hemodialysis)
* Cognitive impairment (i.e., Dementia, Alzheimer's)
* Unable to self-manage (take medication, bathe, use the toilet, etc.)
* Currently living in a nursing home

Conditions2

Heart DiseaseHeart Failure

Locations1 site

University of Illinois, Chicago
Chicago, Illinois, 60612
Jonathan W Leigh, MPH, MSHI312-355-3261leighj@uic.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.